LIFE vs REPL: stock comparison and AI forecast
Atyr Pharma Inc (LIFE) and Replimune Group, Inc. (REPL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
LIFE Atyr Pharma Inc
- Price
- $33.51 +9.5% · 6M
- Market Cap
- $2.14B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
REPL Replimune Group, Inc.
- Price
- $21.62 +547.3% · 6M
- Market Cap
- $2.05B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- LIFE and REPL have similar market capitalizations ($2.14B and $2.05B).
- Over the last six months REPL returned +547.3% and LIFE +9.5%.
- REPL carries 0.83 times debt per unit of equity, against 0.77 times for LIFE.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | LIFE | REPL |
|---|---|---|
| Market Cap | $2.14B | $2.05B |
| P/B Ratio | 62.93x | 10.01x |
| EPS | $-8.08 | $-3.02 |
| Book Value/Share | $0.53 | $2.16 |
| FCF/Share | $-0.69 | $-2.56 |
Profitability & Margins
| Metric | LIFE | REPL |
|---|---|---|
| ROE | – | -132.4% |
| ROA | – | -72.5% |
| ROIC | -129.0% | -82.1% |
| Tax Rate | – | 0.2% |
Financial Health
| Metric | LIFE | REPL |
|---|---|---|
| Current Ratio | 3.05x | 7.11x |
| Quick Ratio | – | 6.90x |
| D/E Ratio | 0.77x | 0.83x |
| Financial Leverage | 1.76x | 1.83x |
| Interest Coverage | -1879.2x | -22.3x |
| Working Capital | $34M | $278M |
Cash Flow
| Metric | LIFE | REPL |
|---|---|---|
| Operating Cash Flow | -$44M | -$246M |
| Free Cash Flow | -$44M | -$243M |
| Capital Spending | -$290K | $3M |
Income Statement
| Metric | LIFE | REPL |
|---|---|---|
| Operating Income | -$56M | -$270M |
| Net Income | – | -$271M |
| R&D Expense | $35M | $189M |
Dividend & Shareholder Information
| Metric | LIFE | REPL |
|---|---|---|
| Shares Outstanding | 64M | 95M |
LIFE vs REPL: stock comparison and AI forecast
Which is bigger, LIFE or REPL?
LIFE and REPL have similar market capitalizations ($2.14B and $2.05B).
Which stock performed better over the last six months, LIFE or REPL?
Over the last six months REPL returned +547.3% and LIFE +9.5%.
Which one does Intratio's AI model rank higher, LIFE or REPL?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.